Oncology Drugs and Ancillary Equipment Tender in Poland - 143771188

Procurement Summary

Country: Poland

Summary: Oncology Drugs and Ancillary Equipment

Deadline: 03 Jul 2026

Posting Date: 22 Jun 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 143771188

Document Ref. No.: 426901-2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33652100 - Antineoplastic agents
33690000 - Various medicinal products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

PART NO. 1 VINORELBINNUM concentrate PART NO. 2 ETOPOSIDUM PART NO. 3 CABAZITAXEL PART NO. 4 LEVOFOLINIC ACID PART NO. 5 TISLELIZUMAB PART NO. 6 Pemigatinibum PART NO. 7 Serplulimabum PART NO. 8 Amivantamab PART NO. 9 Lazertinib PART NO. 10 Afatinib PART NO 11 PORTABLE INFUSION SYSTEM PART NO. 12 PACLITAXEL TRANSFUSION APPARATUS PART NO. 13 AUXILIARY EQUIPMENT PART NO. 14 AVALGLUCOSIDASUM ALFA PART NO. 15 REMDESIVIR PART NO. 16 RAMUCIRUMABUM PART NO. 17 PEMETREXED PART NO. 18 FLUOROURACIL 1) part no. 1 - vinorelbinnum concentrate 2) part no. 2 - etoposidum 3) part no. 3 - cabazitaxel 4) part no. 4 - levofolinic acid 5) part no. 5 - tislelizumab 6) part no. 6 - pemigatinibum 7) part no. 7 - serplulimabum 8) part no. 8 - amivantamab 9) part no. 9 - lazertinib 10) part no 10 - afatinib 11) part no. 11 - portable infusion system 12) lot no. 12 - paclitaxel infusion devices 13) lot no. 13 - auxiliary equipment 14) lot no. 14 - avalglucosidasum alfa 15) lot no. 15 - remdesivir 16) part no. 16 - ramucirumabum 17) part no 17 - pemetrexed 18) part no. 18 - fluorouracil 1Vinorelbinnum, concentrate for solution for infusion 10mg/ml, vial. 5 ml10 vials. 2Vinorelbinnum, concentrate for solution for infusion 10mg/ml, vial. 1 ml250 vials. 1Etoposide 100mg/5ml350fiol. 2Etopozyd 200mg/10 ml250fiol. Cabazitaxel 45 mg/4, 5 ml100szt. 1Levofolinic acid 200mg/4ml200fiol 2Levofolinic acid 450mg/9ml200fiol. Tislelizumab 100 mg/10 ml, koncentrat36fiol. Serplulimabum 10 mg/ml, konc...
Document Type: Contract Notice Reference Number: TP.382.064.2026 OB Contract Type: supplies Authority Type: body-pl Doc Title: Leki onkologiczne i sprzęt pomocniczy Dispatch Date: 2026-06-19 Publish Date: 2026-06-22 Submission Date: 2026-07-03

Documents

 Tender Notice